Paul Scibetta is the Co-Founder and Managing Partner of 22Health Ventures, an early-stage healthtech investment firm established in 2022. Scibetta co-founded Brogent International in 2016, focusing on health technology and precision medicine in Asia. With a strong background in finance and law, they held various leadership positions at JPMorgan, including CEO of JPMorgan Private Bank in Asia and Head of Legal and Compliance for multiple divisions. Additionally, Scibetta has served as a Managing Member at PacificBridge Capital and co-founded several initiatives, including Quiet Revolution and ZiliNet. They earned a BS in Economics from James Madison University and a JD from the University of Pittsburgh School of Law.
This person is not in the org chart
This person is not in any teams
This person is not in any offices